TWO SIGMA ADVISERS, LP - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 129 filers reported holding CHEMOCENTRYX INC in Q4 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$2,446,000
-37.0%
47,341
-69.8%
0.01%
-36.4%
Q2 2022$3,882,000
-29.6%
156,641
-28.8%
0.01%
-26.7%
Q1 2022$5,514,000
+80.0%
219,941
+161.4%
0.02%
+87.5%
Q4 2021$3,064,000
+1902.6%
84,141
+635.4%
0.01%
Q2 2021$153,000
-90.7%
11,441
-64.5%
0.00%
-100.0%
Q1 2021$1,652,000
-86.8%
32,241
-84.1%
0.01%
-84.8%
Q4 2020$12,523,000
-18.4%
202,241
-27.8%
0.03%
-25.0%
Q3 2020$15,341,000
+12.0%
279,941
+17.6%
0.04%
+10.0%
Q2 2020$13,697,000
+142.6%
238,041
+69.4%
0.04%
+81.8%
Q1 2020$5,647,000
-27.4%
140,541
-28.5%
0.02%
+22.2%
Q4 2019$7,777,000
+298.8%
196,641
-31.6%
0.02%
+260.0%
Q3 2019$1,950,000
-32.8%
287,641
-7.8%
0.01%
-28.6%
Q2 2019$2,901,000
-12.5%
311,941
+30.7%
0.01%
-12.5%
Q1 2019$3,314,000
+41.1%
238,617
+10.9%
0.01%
+33.3%
Q4 2018$2,348,000
-18.6%
215,241
-5.7%
0.01%
-14.3%
Q3 2018$2,884,000
-14.0%
228,141
-10.4%
0.01%
-22.2%
Q2 2018$3,354,000
+806.5%
254,641
+836.2%
0.01%
+800.0%
Q1 2018$370,000
+386.8%
27,200
+114.2%
0.00%
Q4 2017$76,000
-19.1%
12,7000.0%0.00%
Q3 2017$94,000
+147.4%
12,700
-17.8%
0.00%
Q1 2016$38,00015,4410.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tri Locum Partners LP 296,327$7,429,0002.90%
Integral Health Asset Management, LLC 400,000$10,028,0002.61%
Cormorant Asset Management, LP 865,000$21,686,0001.66%
HealthCor Management, L.P. 956,740$23,985,0001.60%
Sofinnova Investments, Inc. 573,684$14,382,0001.09%
Lisanti Capital Growth, LLC 321,569$8,062,0000.91%
Cahill Wealth Management, LLC 44,913$1,125,0000.84%
Perceptive Advisors 1,655,079$41,493,0000.83%
RA Capital Management 1,155,964$28,980,0000.63%
Avidity Partners Management LP 1,175,000$29,457,0000.61%
View complete list of CHEMOCENTRYX INC shareholders